Ftse Mib
34.591,01
0,73%
DAX
18.755,77
0,41%
S&P 500
5.216,27
0,04%
NASDAQ
16.314,99
-0,19%
Bitcoin
61.159,09
-3,00%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ NewAmsterdam Pharma Company NV (NAMSW) NewAmsterdam Pharma Company NV (NAMSW) Notizie

NewAmsterdam Pharma Company NV

NAMSW
10,325
0,00 (0,00%)
Ultimo aggiornamento: 17:07:08
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Warrant Azionario
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
09/5/202422:18EDGAR2Form ARS - Annual Report to Security Holders
09/5/202422:15EDGAR2Form DEF 14A - Other definitive proxy statements
09/5/202414:00EDGAR2Form 8-K - Current report
09/5/202414:00GLOBENewAmsterdam Pharma Provides Corporate Update and Reports..
08/5/202422:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/5/202422:01GLOBENewAmsterdam Pharma Reports Inducement Grants Under Nasdaq..
02/5/202414:00GLOBENewAmsterdam Pharma to Host R&D Day with Key Opinion Leaders..
09/4/202414:00GLOBENewAmsterdam Pharma Enrolls Over 9,000 Patients in Pivotal..
01/4/202414:00GLOBENewAmsterdam Pharma Announces the Appointment of Juliette..
25/3/202413:00GLOBENewAmsterdam Pharma to Present New Analysis from the Phase 2..
12/3/202413:00GLOBENewAmsterdam Pharma Doses First Patient in Phase 3 TANDEM..
28/2/202414:00GLOBENewAmsterdam Pharma Reports Full Year 2023 Financial Results..
26/2/202414:00GLOBENewAmsterdam Pharma to Participate in Upcoming Investor..
14/2/202404:40GLOBENewAmsterdam Pharma Announces Pricing of $175.3 Million..
13/2/202422:01GLOBENewAmsterdam Pharma Announces Commencement of Public..
01/2/202422:01GLOBENewAmsterdam Pharma to Present at Guggenheim Healthcare..
08/1/202414:00GLOBENewAmsterdam Pharma Appoints William H. Lewis, J.D., M.B.A...
04/1/202414:00GLOBENewAmsterdam Pharma Announces 2024 Strategic Priorities
13/11/202314:00GLOBENewAmsterdam Pharma Provides Corporate Update and Reports..
23/10/202314:00GLOBENewAmsterdam Pharma Announces Appointment of Ian Somaiya as..
21/9/202313:00GLOBENewAmsterdam Pharma Announces Initial Data from Phase 2a..
20/9/202314:00GLOBENewAmsterdam Pharma to Present at 2023 Cantor Fitzgerald..
14/8/202322:01GLOBENewAmsterdam Pharma Announces Appointment of William “BJ”..
07/8/202313:15GLOBENewAmsterdam Pharma Provides Corporate Update and Reports..
25/7/202322:01GLOBENewAmsterdam Pharma Completes Enrollment in Pivotal Phase 3..
09/6/202322:01GLOBENewAmsterdam Pharma Announces Closing of Upsized Secondary..
07/6/202305:25GLOBENewAmsterdam Pharma Announces Pricing of Upsized Secondary..
06/6/202322:01GLOBENewAmsterdam Pharma Announces Commencement of Secondary..
05/6/202313:00GLOBENewAmsterdam Pharma Announces Positive Topline Results from..
03/6/202318:15GLOBENewAmsterdam Pharma Presents Full Data from Phase 2 ROSE2..
31/5/202314:00GLOBENewAmsterdam Pharma to Present at Jefferies Healthcare..
23/5/202314:00GLOBENewAmsterdam to Present Full Data from ROSE2 at NLA..
Apertura: Min: Max:
Chiusura: 10,325

La tua Cronologia

NASDAQ
NAMSW
NewAmsterdam Pharma Comp...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network